ArticleThoracic cancer2026

Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.

Wira Winardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.